De Giorgis M

No ORCID on file · 1 paper in corpus

2026

MUC1/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature.

Clinical and experimental medicine ·doi:10.1007/s10238-026-02042-5

Clear cell renal carcinoma (ccRCC) is a prevalent kidney cancer with limited effective biomarkers for prognosis and treatment guidance. Despite advancements, a significant portion of ccRCC cases progress to advanced stages, necessitating no…